Heart Health Doulas Trial for Hypertensive Disorders of Pregnancy
This study is testing whether a "Heart Health Doula Intervention Program" can improve blood pressure in women who have high blood pressure during or after pregnancy (hypertensive disorder of pregnancy). This program includes a smart blood pressure cuff, a smart scale, and support from a doula trained in heart health until 8-12 weeks after birth. You could join if you are pregnant or recently gave birth, are 18 or older, have a hypertensive disorder of pregnancy, and live in or near Allegheny, Westmoreland, Beaver, Butler, or Washington County. The study aims to see if this support helps lower blood pressure at 12 months postpartum. The study status is unclear.
- Study design
- This is a single-site, single-blinded study comparing two groups of participants, with 454 women expected to enroll. Participants will be randomly assigned to either receive usual care or the Heart Health Doula Intervention Program.
- What's involved
- Participants will be enrolled during their third trimester or up to two weeks after delivery. The study will involve monitoring blood pressure and weight, and weekly doula sessions for those in the intervention group, completing around 12 months postpartum.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for approximately 12 months postpartum to assess their blood pressure.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Janet Catov, PhD · PRINCIPAL_INVESTIGATOR · University of Pittsburgh
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Assess MAP at 12 months postpartumBaseline to approximately 12 months postpartum
To test the effectiveness of the postpartum Doula intervention the investigators will evaluate blood pressure and mean arterial pressure (MAP) at 12 months postpartum.